{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:47:37Z","timestamp":1765738057611,"version":"3.48.0"},"reference-count":24,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,3,3]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Most patients with small cell lung cancer present with extensive-stage (ES-SCLC) disease. An international randomised trial demonstrated a survival benefit in patients treated with consolidative thoracic radiotherapy (cTRT). We report our institutional experience with this regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective review was conducted on patients with ES-SCLC who were candidates for cTRT at our institution between 2013 and 2022. The patients included in our study had biopsy-proven ES-SCLC, received \u22654 cycles of chemotherapy and achieved complete response, partial response or stable disease as per Response Evaluation Criteria in Solid Tumors V.1.1. Overall survival, progression-free survival (PFS) and recurrence patterns were compared between patients who received cTRT and those who did not. For patients who received cTRT, treatment tolerability was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 123 patients with ES-SCLC who received \u22654 cycles of chemotherapy and were candidates for cTRT. Of those, 49 patients received cTRT, and 74 patients did not. From the end of chemotherapy, the control group had a median OS of 0.6 years with a 1- and 2-year OS of 23.5% and 11.0%. Within the cTRT group, the median OS was 0.9 years with a 1- and 2-year OS of 46.7% and 26.3%. Within the control group, the median PFS was 0.2 years compared with 0.4 years within the cTRT group. Intrathoracic failures in the cTRT group were lower compared with the control group (16.3% vs 29.7%). cTRT was well tolerated with no grade 3+ toxicities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The improved clinical outcomes of cTRT for patients with ES-SCLC were comparable to the reported the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST) outcome, with a low rate of side effects in our study cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-093943","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T23:43:15Z","timestamp":1742773395000},"page":"e093943","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective cohort study assessing clinical outcomes of patients with extensive-stage small cell lung cancer treated with and without consolidative thoracic radiotherapy at the Princess Margaret Cancer Centre"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5326-1695","authenticated-orcid":false,"given":"Vijithan","family":"Sugumar","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"},{"name":"Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Salunkhe","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"},{"name":"Department of Radiation Oncology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadee","family":"Lone","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luna","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Sun","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"},{"name":"Department of Radiation Oncology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bezjak","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"},{"name":"Department of Radiation Oncology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Cho","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"},{"name":"Department of Radiation Oncology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Raman","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"},{"name":"Department of Radiation Oncology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hope","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"},{"name":"Department of Radiation Oncology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Giuliani","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"},{"name":"Department of Radiation Oncology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha B","family":"Leighl","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian G","family":"Sacher","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penelope A","family":"Bradbury","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Lok","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"},{"name":"Department of Radiation Oncology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"2025121410423779000_15.3.e093943.1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025121410423779000_15.3.e093943.2","unstructured":"American Cancer Society . Cancer Facts & Statistics, Available: http:\/\/cancerstatisticscenter.cancer.org\/"},{"key":"2025121410423779000_15.3.e093943.3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"2025121410423779000_15.3.e093943.4","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0659"},{"key":"2025121410423779000_15.3.e093943.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.09.009"},{"key":"2025121410423779000_15.3.e093943.6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29098"},{"key":"2025121410423779000_15.3.e093943.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901283400403"},{"key":"2025121410423779000_15.3.e093943.8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0169-5002(02)00072-7","article-title":"Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer\u2014what limits limited disease?","volume":"37","author":"Micke","year":"2002","journal-title":"Lung Cancer (Auckl)"},{"key":"2025121410423779000_15.3.e093943.9","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum\u2013etoposide versus platinum\u2013etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"The Lancet"},{"key":"2025121410423779000_15.3.e093943.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30318-2"},{"key":"2025121410423779000_15.3.e093943.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809064"},{"key":"2025121410423779000_15.3.e093943.12","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1999.17.7.2092","article-title":"Role of Radiation Therapy in the Combined-Modality Treatment of Patients With Extensive Disease Small-Cell Lung Cancer: A Randomized Study","volume":"17","author":"Jeremic","year":"1999","journal-title":"JCO"},{"key":"2025121410423779000_15.3.e093943.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61085-0"},{"key":"2025121410423779000_15.3.e093943.14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cllc.2011.03.028","article-title":"Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy","volume":"12","author":"Giuliani","year":"2011","journal-title":"Clin Lung Cancer"},{"key":"2025121410423779000_15.3.e093943.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.03.081"},{"key":"2025121410423779000_15.3.e093943.16","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.240095"},{"key":"2025121410423779000_15.3.e093943.17","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jtho.2017.06.015","article-title":"Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937","volume":"12","author":"Gore","year":"2017","journal-title":"J Thorac Oncol"},{"key":"2025121410423779000_15.3.e093943.18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejca.2019.01.003","article-title":"Role of thoracic consolidation radiation in extensive stage small cell lung cancer: A systematic review and meta-analysis of randomised controlled trials","volume":"110","author":"Rathod","year":"2019","journal-title":"Eur J Cancer"},{"key":"2025121410423779000_15.3.e093943.19","doi-asserted-by":"crossref","first-page":"107166","DOI":"10.1016\/j.lungcan.2023.03.002","article-title":"Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations","volume":"179","author":"Sun","year":"2023","journal-title":"Lung Cancer (Auckl)"},{"key":"2025121410423779000_15.3.e093943.20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.prro.2020.02.009","article-title":"Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline","volume":"10","author":"Simone","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"2025121410423779000_15.3.e093943.21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cllc.2023.08.009","article-title":"The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series","volume":"24","author":"Gross","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"2025121410423779000_15.3.e093943.22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1289434","article-title":"Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy","volume":"14","author":"Longo","year":"2023","journal-title":"Front Immunol"},{"key":"2025121410423779000_15.3.e093943.23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13014-024-02420-x","article-title":"Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis","volume":"19","author":"Yao","year":"2024","journal-title":"Radiat Oncol"},{"key":"2025121410423779000_15.3.e093943.24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00793"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-093943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:42:44Z","timestamp":1765737764000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-093943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,21]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjopen-2024-093943"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-093943","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}